Verve Therapeutics, Inc. - COM (VERV)

Historical Portfolio Holders from Q2 2021 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
1.73 M
Holdings value Q1 2024
$22.9 M
Value change Q1 2024
+$7.74 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
7
Number of buys Q1 2024
6
Number of sells Q1 2024
-19
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
92539P101
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 1.73 M $22.9 M +$7.74 M $13.28 7
2023 Q4 74.3 M $1.04 B +$151 M $13.94 150
2023 Q3 63.8 M $846 M +$19.5 M $13.26 129
2023 Q2 61.7 M $1.16 B -$20.1 M $18.75 114
2023 Q1 63.3 M $912 M +$3.33 M $14.42 122
2022 Q4 62.6 M $1.21 B +$9.15 M $19.35 116
2022 Q3 60.4 M $2.07 B +$501 M $34.35 119
2022 Q2 45.4 M $693 M -$28.2 M $15.28 92
2022 Q1 46.6 M $1.06 B +$20 M $22.82 91
2021 Q4 45.1 M $1.66 B +$125 M $36.87 87
2021 Q3 38.7 M $1.81 B +$24.1 M $47.00 72
2021 Q2 37.7 M $2.25 B +$2.25 B $60.25 69